Kairos Pharma
KAPA
8 hedge funds and large institutions have $1.46M invested in Kairos Pharma in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
137% more capital invested
Capital invested by funds: $618K → $1.46M (+$845K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
60% more funds holding
Funds holding: 5 → 8 (+3)
8.35% more ownership
Funds ownership: 3.16% → 11.51% (+8.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.8M |
| 2 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
+$61.7K |
| 3 |
ACA
Aptus Capital Advisors
Fairhope,
Alabama
|
+$56.7K |
| 4 |
SFG
SevenBridge Financial Group
Harrisburg,
Pennsylvania
|
+$56.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$26.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UB
UMB Bank
Kansas City,
Missouri
|
-$564K |
| 2 |
VF
Virtu Financial
New York
|
-$21K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $1.31M | +$1.8M | +1,404,000 | New |
|
|
SRL
2
Scientech Research LLC
Jersey City,
New Jersey
| $45.1K | +$61.7K | +48,198 | New |
|
|
ACA
3
Aptus Capital Advisors
Fairhope,
Alabama
| $41.5K | +$56.7K | +44,286 | New |
|
|
SFG
4
SevenBridge Financial Group
Harrisburg,
Pennsylvania
| $28.3K | +$56.7K | +44,286 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $19.1K | +$26.2K | +20,433 | New |
|
6
Citadel Advisors
Miami,
Florida
| $12.4K | +$2.9K | +2,261 | +21% |
|
|
7
UBS Group
Zurich,
Switzerland
| $2.61K | -$10.3K | -8,053 | -74% |
|
8
Bank of America
Charlotte,
North Carolina
| $20 | +$10 | +8 | +62% |
|
|
UB
9
UMB Bank
Kansas City,
Missouri
| – | -$564K | -371,115 | Closed |
|
|
VF
10
Virtu Financial
New York
| – | -$21K | -13,656 | Closed |
|
KAPA Hedge Fund Activity: Q1 2025 in Review
8 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Kairos Pharma (KAPA) for Q1 2025, worth a combined $1.46M — up 137% from $618K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new KAPA positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.8M. The largest seller was UMB Bank, exiting entirely with an estimated $564K sold.
- 8 institutional investors held Kairos Pharma (KAPA) as of Q1 2025, up from 5 in Q4 2024.
- Funds reported $1.46M of Kairos Pharma stock for Q1 2025, up 137% quarter-over-quarter.
- 5 funds opened new Kairos Pharma positions in Q1 2025 and 2 closed out, a net change of +3 holders.
- The largest Kairos Pharma buyer in Q1 2025 was Armistice Capital, an estimated $1.8M added.
- The largest Kairos Pharma seller in Q1 2025 was UMB Bank, an estimated $564K sold.
Based on aggregated 13F filings for Q1 2025.